IWC
LENZ

Integrated Wealth Concepts’s LENZ Therapeutics LENZ Stock Holding History

Integrated Wealth Concepts’s Portfolio LENZ Stock Details LENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22.7K Buy
+4,004
New +$32.3K ﹤0.01% 3983

Other funds holding LENZ

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
AWG
Alpha Wave Global New York $6.24B AUM 59.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
7IH
72 Investment Holdings Stamford, Connecticut $50M AUM 647.58% 1-Year Est. Return

Integrated Wealth Concepts's LENZ Position: Q2 2026 in Review

Integrated Wealth Concepts opened a new position in LENZ Therapeutics (LENZ) in Q2 2026: 4,004 shares worth $22.7K. The stake represents ﹤0.01% of the portfolio and ranks #3983 among its holdings.

144 funds tracked by Wall St. Rank hold LENZ as of Q2 2026.

  • Integrated Wealth Concepts held 4,004 shares of LENZ Therapeutics worth $22.7K as of Q2 2026.
  • LENZ Therapeutics was a new Integrated Wealth Concepts position in Q2 2026.
  • LENZ Therapeutics made up ﹤0.01% of Integrated Wealth Concepts's portfolio in Q2 2026, its #3983 holding.
  • 144 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q2 2026.

Based on Integrated Wealth Concepts's 13F filing for Q2 2026, filed 12 Aug 2026.